Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Carter Bankshares, Inc.NASDAQ: CARE
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $112.16M rose 759.7% year over year, ahead of the +249.4% change in trailing-twelve-month EBITDA. Sequentially, it rose 754.4% from the prior quarter. Over 3 fiscal years it compounded at -11.0% a year.
Context
- EBITDA amounted to 18.8% of revenue in FY2025, up 3.0 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $177.06M (+270.0%) for the fiscal year ending Dec 2026, a step up from the +26.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $112.16M+754.4% QoQ
- Last fiscal yearDec 2025
- $47.86M+26.2% YoY
- LTMMar 2026
- $146.98M+249.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +759.7% | +222.5% | -537.1 pp |
| 1 year | +26.2% | +270.0% | +243.8 pp |
| 3-year CAGR | -11.0% | +22.6% | +33.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 47.86M USD
- Year-over-year change
- +26.2%
- 4-year CAGR
- +3.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.86M | +26.2% |
| FY2024 | 2024-12-31 | 37.92M | +8.5% |
| FY2023 | 2023-12-31 | 34.97M | -48.4% |
| FY2022 | 2022-12-31 | 67.78M | +61.7% |
| FY2021 | 2021-12-31 | 41.93M | — |
EBITDA vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 EBITDA of $146.98M is the highest of the 11 companies compared; the peer median is $42.4M.
- Its year-over-year change of +249.4% is the 2nd highest of 11, against a peer median of +25.1%.
- EBITDA amounts to 45.9% of revenue for CARE, versus a peer median of 24.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $146.98M | +249.4% | -11.0% | 45.9% | |
| LTM Mar 2026 | $69.33M | -2.2% | +1.5% | 39.6% | |
| LTM Mar 2026 | $59.23M | +4.8% | +7.6% | 23.9% | |
| LTM Mar 2026 | $58.11M | +176.4% | +0.8% | 27.4% | |
| LTM Mar 2026 | $49.37M | +75.0% | +2.0% | 24.0% | |
| LTM Mar 2026 | $46.19M | -17.9% | -5.3% | 19.0% | |
| LTM Mar 2026 | $38.6M | +26.3% | -4.0% | 20.4% | |
| LTM Mar 2026 | $30.42M | +23.9% | -3.4% | 24.8% | |
| LTM Mar 2026 | $22.84M | +96.8% | -13.9% | 26.5% | |
| LTM Mar 2026 | $17.67M | +252.6% | -16.4% | 12.3% | |
| LTM Mar 2026 | -$154.17M | -466.5% | — | 25.0% | |
| Peer median (excluding CARE) | $42.4M | +25.1% | -3.4% | 24.4% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 156.38M | 179.15M | 211.82M | 239.67M | 254.63M |
| Cost of Revenue | 24.8M | 23.18M | 80.51M | 102.23M | 97.57M |
| Gross Profit | 131.58M | 155.97M | 131.31M | 137.45M | 157.06M |
| Gross Margin | 84.1% | 87.1% | 62.0% | 57.3% | 61.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 57.27M | 55.85M | 62.45M | 66.65M | 75.36M |
| Operating Expenses | 95.89M | 94.25M | 102.59M | 106.58M | 117.05M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| EBITDA | 41.93M | 67.78M | 34.97M | 37.92M | 47.86M |
| EBITDA Margin | 26.8% | 37.8% | 16.5% | 15.8% | 18.8% |
| Operating Income | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Operating Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Interest Income | 133.78M | 160.03M | 194.96M | 220.72M | 232.22M |
| Interest Expense | 22.71M | 20.25M | 74.11M | 107.27M | 101.4M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Pre-Tax Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Income Tax Expense | 4.11M | 11.6M | 5.34M | 6.35M | 8.64M |
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Net Margin | 20.2% | 28.0% | 11.0% | 10.2% | 12.3% |
| EPS (Basic) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| EPS (Diluted) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| Weighted Avg Shares | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
| Weighted Avg Shares (Diluted) | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.